Austràlia - anglès - APVMA (Australian Pesticides and Veterinary Medicines Authority)

akzo nobel pty limited - copper present as cuprous oxide; copper pyrithione - paint - copper present as cuprous oxide mineral-copper active 794.0 g/l; copper pyrithione mineral-copper active 84.0 g/l - antifouling

Estats Units - anglès - myHealthbox

ecolab -

Austràlia - anglès - APVMA (Australian Pesticides and Veterinary Medicines Authority)

imtrade australia pty ltd - dimethoate - emulsifiable concentrate - dimethoate organophosphorus-dithiophospha active 400.0 g/l - insecticide

Austràlia - anglès - APVMA (Australian Pesticides and Veterinary Medicines Authority)

akzo nobel pty limited - zineb; zineb; copper present as cuprous oxide; copper present as cuprous oxide; liquid hydrocarbon; liquid hydrocarbon; liquid hydrocarbon; liquid hydrocarbon - paint - zineb carbamate-dithiocarbamate active 90.0 g/l; zineb carbamate-dithiocarbamate active 88.0 g/l; copper present as cuprous oxide mineral-copper active 710.0 g/l; copper present as cuprous oxide mineral-copper active 694.0 g/l; liquid hydrocarbon solvent other 357.0 g/l; liquid hydrocarbon solvent other 364.0 g/l; liquid hydrocarbon solvent other 365.0 g/l; liquid hydrocarbon solvent other 374.0 g/l - antifouling

Estats Units - anglès - NLM (National Library of Medicine)

energique, inc. - acetone (unii: 1364ps73af) (acetone - unii:1364ps73af), sodium tripolyphosphate (unii: 5hk03sa80j) (tripolyphosphate ion - unii:5798iya5ay), propylene glycol (unii: 6dc9q167v3) (propylene glycol - unii:6dc9q167v3), benzene (unii: j64922108f) (benzene - unii:j64922108f), ammonium chloride (unii: 01q9pc255d) (ammonium cation - unii:54s68520i4), sodium lauryl sulfate (unii: 368gb5141j) (lauryl sulfate - unii:diq16uc154), turpentine oil (unii: c5h0qj6v7f) (turpentine oil - unii:c5h0qj6v7f), butyl acetate - may temporariy relieve symptoms associated with household chemicals sensitivities, such as dizziness and headache.** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated. may temporariy relieve symptoms associated with household chemicals sensitivities, such as dizziness and headache.** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

agilent technologies australia pty ltd - ct945 - general laboratoryware ivds - clearify? is an odorless biodegradable clearing agent designed as an alternative to xylene and intended for in vitro diagnostic use. clearify? can generally be used as a substitute for xylene both manually and in tissue processors. clearify? is miscible with histology embedding mediums and compatible with most mounting mediums.

Estats Units - anglès - NLM (National Library of Medicine)

energique, inc. - acetone (unii: 1364ps73af) (acetone - unii:1364ps73af), sodium tripolyphosphate (unii: 5hk03sa80j) (tripolyphosphate ion - unii:5798iya5ay), propylene glycol (unii: 6dc9q167v3) (propylene glycol - unii:6dc9q167v3), sodium benzenesulfonate (unii: k5rm14azhx) (benzenesulfonic acid - - unii:685928z18a), ammonium chloride (unii: 01q9pc255d) (ammonium cation - unii:54s68520i4), sodium lauryl sulfate (unii: 368gb5141j) (lauryl sulfate - unii:diq16uc154), turpentine oil (unii: c5h0qj6v7f) (turpentine oil - - acetone 9 [hp_x] in 1 ml - indications: for temporary relief of allergies due to household chemicals. indications: for temporary relief of allergies due to household chemicals.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - norethisterone acetate, quantity: 4.8 mg (equivalent: estradiol hemihydrate, qty 0.806 mg; equivalent: norethisterone acetate, qty 250 microgram/24 h); estradiol, quantity: 0.512 mg (equivalent: estradiol, qty 50 microgram/24 h; equivalent: estradiol hemihydrate, qty 0.529 mg) - drug delivery system, transdermal - excipient ingredients: oleic acid; povidone; dipropylene glycol; polytrimethylhydrosilylsiloxane; xylene; ammonia; toluene; 1,1,1-trimethyl-n-(trimethylsilyl)silanamine; dimeticonol; polyethylene terephthalate; polyvinylidene flouride; ethyl acetate; ethanol; acrylates/va copolymer; ethylene/vinyl acetate copolymer - for the short-term treatment of symptoms of oestrogen deficiency in menopausal women who have an intact uterus. combination hrt should not be used in hysterectomised women because it is not needed in these women and it may increase the risk of breast cancer.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - norethisterone acetate, quantity: 2.7 mg (equivalent: estradiol hemihydrate, qty 0.806 mg; equivalent: norethisterone acetate, qty 140 microgram/24 h); estradiol, quantity: 0.62 mg (equivalent: estradiol, qty 50 microgram/24 h; equivalent: estradiol hemihydrate, qty 0.64 mg) - drug delivery system, transdermal - excipient ingredients: povidone; oleic acid; dipropylene glycol; polytrimethylhydrosilylsiloxane; xylene; ammonia; toluene; 1,1,1-trimethyl-n-(trimethylsilyl)silanamine; dimeticonol; ethyl acetate; ethanol; acrylates/va copolymer; polyethylene terephthalate; polyvinylidene flouride; ethylene/vinyl acetate copolymer - for the short-term treatment of symptoms of oestrogen deficiency in menopausal women who have an intact uterus. combination hrt should not be used in hysterectomised women because it is not needed in these women and it may increase the risk of breast cancer.

Estats Units - anglès - NLM (National Library of Medicine)

professional complementary health formulas - cimicifuga racemosa 3x gelsemium sempervirens 3x nux vomica 6x berberis vulgaris 10x chelidonium majus 10x anilinum 12x cyclohexanol 12x estradiol benzoate 12x phenylmercuric nitrate 12x toluol 12x xylol 12x benzinum 14x - for the temporary relief of occasional headache, cough, minor sore throat, red or irritated skin or eyes, weakness, nausea, or vomiting.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.